ImmuPharma PLC Net Asset Quality Index
ImmuPharma PLC net asset quality index. ImmuPharma PLC (IMM) has a Net Asset Quality Index of 21.3% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of GBX1.58 Million minus total liabilities of GBX1.24 Million yields net assets of GBX336.70K. A higher index indicates a stronger, lower-leverage balance sheet. See net assets of ImmuPharma PLC for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of ImmuPharma PLC (2004–2024)
Net asset quality index of ImmuPharma PLC from 2004 to 2024. This chart shows how ImmuPharma PLC's Net Asset Quality Index has evolved across 22 annual periods from 2004 to 2024. As of June 2025, the index stands at 21.3%, representing net assets of GBX336.70K against total assets of GBX1.58 Million GBX. Check IMM capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
ImmuPharma PLC Net Asset Quality Index by Year (2004–2024)
ImmuPharma PLC net asset quality index by year from 2004 to 2024. The table below presents the year-by-year Net Asset Quality Index for ImmuPharma PLC from 2004 to 2024, covering 22 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ImmuPharma PLC (IMM) market capitalisation.
| Year | Quality Index | Net Assets (GBX) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -55.6% | GBX-542.86K | GBX977.01K | GBX1.52 Million | ▼ -94.4 pp |
| 2023 | 38.8% | GBX1.06 Million | GBX2.72 Million | GBX1.67 Million | ▼ -24.7 pp |
| 2022 | 63.5% | GBX2.52 Million | GBX3.97 Million | GBX1.45 Million | ▼ -10.1 pp |
| 2021 | 73.6% | GBX4.41 Million | GBX6.00 Million | GBX1.58 Million | ▼ -14.9 pp |
| 2020 | 88.4% | GBX9.65 Million | GBX10.92 Million | GBX1.26 Million | ▼ -2.4 pp |
| 2019 | 90.8% | GBX5.27 Million | GBX5.80 Million | GBX531.87K | ▲ +2.8 pp |
| 2018 | 88.0% | GBX7.62 Million | GBX8.66 Million | GBX1.03 Million | ▲ +16.8 pp |
| 2017 | 71.2% | GBX3.57 Million | GBX5.02 Million | GBX1.44 Million | ▼ -11.4 pp |
| 2016 | 82.7% | GBX5.55 Million | GBX6.71 Million | GBX1.16 Million | ▲ +30.0 pp |
| 2015 | 52.6% | GBX1.69 Million | GBX3.21 Million | GBX1.52 Million | ▼ -28.1 pp |
| 2014 | 80.7% | GBX5.71 Million | GBX7.07 Million | GBX1.37 Million | ▲ +5.7 pp |
| 2013 | 75.0% | GBX5.40 Million | GBX7.21 Million | GBX1.80 Million | ▼ -5.1 pp |
| 2012 | 80.1% | GBX8.42 Million | GBX10.51 Million | GBX2.09 Million | ▼ -7.5 pp |
| 2011 | 87.6% | GBX12.51 Million | GBX14.28 Million | GBX1.77 Million | ▼ -3.4 pp |
| 2010 | 91.0% | GBX15.97 Million | GBX17.55 Million | GBX1.58 Million | ▲ +17.6 pp |
| 2009 | 73.4% | GBX18.08 Million | GBX24.64 Million | GBX6.56 Million | ▼ -10.5 pp |
| 2008 | 83.9% | GBX11.24 Million | GBX13.40 Million | GBX2.16 Million | ▲ +9.5 pp |
| 2007 | 74.4% | GBX3.05 Million | GBX4.10 Million | GBX1.05 Million | ▼ -6.0 pp |
| 2006 | 80.4% | GBX5.89 Million | GBX7.33 Million | GBX1.44 Million | ▲ +11.3 pp |
| 2006 | 69.0% | GBX2.50 Million | GBX3.63 Million | GBX1.12 Million | ▼ -29.6 pp |
| 2005 | 98.6% | GBX993.00K | GBX1.01 Million | GBX14.00K | ▼ -1.2 pp |
| 2004 | 99.8% | GBX978.00K | GBX980.00K | GBX2.00K | — |